Figure 2
From: The impact of COVID-19 on microRNA and CD marker expression in AML patients
Assessment of microRNA expression and its association with CD markers. (A) Differential microRNA expression between AML patients and healthy controls. (B) Spearman correlation coefficient analysis of microRNA expression levels, examining the associations and relationships between different microRNAs. (C) Spearman correlation coefficient analysis of microRNA expression levels with CD Markers. (D) Spearman correlation coefficient between each microRNA with FISH and genetic abnormalities ratios in AML patients.
